Financial Performance - For the six months ended June 30, 2022, the group achieved a consolidated revenue of RMB 205,210,475, a decrease of 15.13% compared to RMB 241,786,926 for the same period last year[6] - The consolidated gross profit for the same period was RMB 10,370,957, representing a significant decrease of 63.05% from RMB 28,064,013 in the previous year[6] - The loss attributable to equity holders for the six months ended June 30, 2022, was RMB 13,248,062, compared to a profit of RMB 809,551 for the same period last year, resulting in a basic loss per share of RMB 0.699[6] - Total revenue for the six months ended June 30, 2022, was RMB 205,210,475, a decrease from RMB 241,786,926 in the same period of 2021, representing a decline of approximately 15%[13] - The company reported a net loss before tax of RMB (13,248) for the six months ended June 30, 2022, compared to a loss of RMB (1,876) in the same period of 2021[18] - The company reported a basic loss per share of RMB (13,248,062) for the six months ended June 30, 2022, compared to a profit of RMB 809,551 in the same period of 2021[19] Assets and Liabilities - Non-current assets as of June 30, 2022, totaled RMB 138,480,513, slightly down from RMB 138,846,665 as of December 31, 2021[8] - Current assets increased significantly to RMB 361,364,056 as of June 30, 2022, compared to RMB 208,748,747 as of December 31, 2021[8] - The total current liabilities amounted to RMB 363,481,875, significantly higher than RMB 192,023,885 in the previous year[10] - The total assets minus current liabilities stood at RMB 136,362,694, a decrease from RMB 155,571,527 in the previous year[10] - As of June 30, 2022, the total assets were approximately RMB 499,844,569, with total liabilities of RMB 363,481,875, leading to a debt-to-asset ratio of 0.79[37] Cash Flow and Financing - Operating cash flow for the six months ended June 30, 2022, was a net outflow of RMB 21,636,996, compared to a net outflow of RMB 17,966,948 in the same period of 2021[11] - The cash and bank balances decreased to RMB 5,204,067 at the end of the period, down from RMB 26,789,577 at the end of the previous year[11] - The company raised RMB 30,000,000 from short-term/long-term bank loans during the financing activities for the six months ended June 30, 2022[11] - Financing costs increased significantly to RMB 3,330,598 for the six months ended June 30, 2022, compared to RMB 735,141 in the same period last year[7] - The company incurred financing expenses of RMB 3,330,598 for the six months ended June 30, 2022, compared to RMB 735,141 in the same period of 2021[14] Expenses - Research and administrative expenses for the six months ended June 30, 2022, were RMB 12,242,150, down from RMB 14,279,494 in the previous year[7] - Sales and distribution costs decreased by 38.11% year-on-year to RMB 8,118,740, down from RMB 13,117,605 in the previous year[32] - R&D and administrative expenses were RMB 12,242,150, reflecting a year-on-year decrease of 14.27% from RMB 14,279,494[33] - Financing costs surged by 453.06% year-on-year to RMB 3,330,598, compared to RMB 735,141 in the same period last year[34] Shareholder Information - The company did not recommend the payment of any dividend for the six months ended June 30, 2022[6] - The company did not recommend an interim dividend for the six months ended June 30, 2022, compared to no dividend in the same period of 2021[28] - The major shareholders include Tianjin Economic and Technological Development Zone State-owned Assets Management Co., Ltd. with 182,500,000 shares (9.63%), Shenzhen Xiangyong Investment Co., Ltd. with 180,000,000 shares (9.50%), and Guangdong Jiamei Ecological Technology Co., Ltd. with 180,000,000 shares (9.50%) [46] Business Operations - The company is involved in two main business areas: bio-composite fertilizers and elderly care services, with ongoing adjustments to product structure and sales management in response to market demand[29] - The company faced increased production costs for bio-composite fertilizers due to rising raw material prices and logistics costs, but successfully passed some of these costs onto customers[29] - The company plans to enhance marketing management and adjust product structure to improve market share in the compound fertilizer sector[41] - The aging population in China reached 264 million, accounting for 18.7% of the total population, indicating a growing demand for elder care services[42] - The company aims to develop its rental business for elderly aids, leveraging its management of multiple elder care institutions in Shanghai[42] Corporate Governance - The company has established an audit committee to oversee financial reporting and internal controls[53] - The board believes that the dual role of the chairperson and CEO held by Ms. Sun Li is in the best interest of the company for maintaining policy continuity and operational stability[59] - The company is actively seeking candidates for the CEO position to enhance corporate governance transparency and independence[59] - The company has complied with all provisions of the corporate governance code except for the separation of the roles of chairperson and CEO[59] - There were no arrangements that allowed directors or supervisors to profit from purchasing company shares during the review period[45] - The company has not entered into any management contracts for overall or major business operations during the first half of 2022[56] - The company did not approve any new share option plans during the period ending June 30, 2022 [55] - There were no securities transactions by directors that violated trading rules during the review period[57] Audit and Financial Reporting - The audit committee reviewed the interim results and report for the six months ending June 30, 2022 [54] - The company has not recognized any significant capital commitments not provided for in the financial statements as of June 30, 2022[26]
泰达生物(08189) - 2022 - 中期财报